Skip to content

The quit smoking lung health intervention trial

QuLIT – the Quit smoking Lung health Intervention Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12455871
Enrollment
130
Registered
2019-06-27
Start date
2019-08-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking cessation Mental and Behavioural Disorders Mental and behavioural disorders due to use of tobacco

Interventions

Current interventions as of 25/06/2021: A study comparing the effectiveness of two different smoking cessation strategies applied in a pseudo-randomised fashion. Smokers attending a lung health screen

Sponsors

Imperial College London
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current participant inclusion criteria as of 24/06/2021: 1. Participant in the clinical lung health screening programme (aged 55 to 75 years recorded as ever smokers in their medical records) 2. Current smoker 3. Only those who express a wish to quit smoking will be included in the primary endpoint analysis Previous participant inclusion criteria: 1. Participant in the clinical lung health screening programme (aged 50 to 65 years and any history of smoking) 2. Current smoker 3. Only those who express a wish to quit smoking will be included in the primary endpoint analysis

Exclusion criteria

Exclusion criteria: Non-smokers

Design outcomes

Primary

MeasureTime frame
Quit rate in those wishing to quit, based on self-report by telephone call at 3 months following the initial screening visit

Secondary

MeasureTime frame
Current secondary outcome measures as of 18/05/2022: 1. Quit rate in all screening program participants, based on self-report by telephone call at 3 months following the initial screening visit 2. Mortality at 1 year (available as part of the routine evaluation of the screening protocol) 3. Quit rate at 1 year Exploratory outcomes: 1. The impact of the smoking cessation interventions (based on self-report by telephone call at three months) in different baseline groups including: 1.1. Those with new abnormal findings found as part of screening (e.g. spirometry) 1.2. Those with or without an abnormal CT finding that requires further follow up 2. The number of individuals who are smoking and who wish to quit will also be documented to provide guidance for service development and resource requirements Previous secondary outcome measures: 1. Quit rate in all screening program participants, based on self-report by telephone call at 3 months following the initial screening visit 2. Mortality at 1 year (available as part of the routine evaluation of the screening protocol) Exploratory outcomes: 1. The impact of the smoking cessation interventions (based on self-report by telephone call at three months) in different baseline groups including: 1.1. Those with new abnormal findings found as part of screening (e.g. spirometry) 1.2. Those with or without an abnormal CT finding that requires further follow up 2. The number of individuals who are smoking and who wish to quit will also be documented to provide guidance for service development and resource requirements

Countries

England, United Kingdom

Contacts

Public ContactAhmad Sadaka

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 13, 2026